AbbVie Raises Shire Offer To $51B, Stoking Buyout Battle

AbbVie Inc. on Tuesday boosted its offer for rival drugmaker Shire PLC to £30.1 billion ($51.3 billion), its latest attempt at a power play in the intensifying buyout fight after a...

Already a subscriber? Click here to view full article